873551-53-2

873551-53-2 structure
873551-53-2 structure
  • Name: FTIDC
  • Chemical Name: FTIDC
  • CAS Number: 873551-53-2
  • Molecular Formula: C18H23FN6O
  • Molecular Weight: 358.413
  • Catalog: Signaling Pathways GPCR/G Protein mGluR
  • Create Date: 2018-06-10 03:36:42
  • Modify Date: 2024-01-10 17:42:53
  • FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].

Name FTIDC
Synonyms 4-[1-(2-Fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydro-1(2H)-pyridinecarboxamide
1(2H)-Pyridinecarboxamide, 4-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-
FTIDC
Description FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].
Related Catalog
Target

mGluR1a:5.8 nM (IC50)

mGluR5:6200 nM (IC50)

In Vitro FTIDC inhibits L-glutamate-induced increases in intracellular Ca2+ concentrations, with IC50 values of 5.8 nM , 5.8 nM , 3.1 nM , 7.7 nM for human mGluR1a, rat mGluR1a, mouse mGluR1a, human mGluR1b in CHO cells, respectively[1].
In Vivo FTIDC (i.p. or p.o.; 1-30 mg/kg) reduces the duration of face-washing behavior elicited in a dosedependent manner and the inhibitory effect is statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o.[1]. Animal Model: Male CD1 (ICR) mice of 6-weeks-old[1] Dosage: 1, 3, 10, and 30 mg/kg Administration: I.p. or p.o. Result: Reduced the duration of face-washing behavior elicited in a dosedependent manner and was statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o..
References

[1]. Suzuki G, et al. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53.

Density 1.3±0.1 g/cm3
Boiling Point 558.2±60.0 °C at 760 mmHg
Molecular Formula C18H23FN6O
Molecular Weight 358.413
Flash Point 291.4±32.9 °C
Exact Mass 358.191742
LogP 2.15
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.624
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.